| pubmed-article:9269636 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9269636 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:9269636 | lifeskim:mentions | umls-concept:C0006684 | lld:lifeskim |
| pubmed-article:9269636 | lifeskim:mentions | umls-concept:C0007226 | lld:lifeskim |
| pubmed-article:9269636 | lifeskim:mentions | umls-concept:C0021641 | lld:lifeskim |
| pubmed-article:9269636 | lifeskim:mentions | umls-concept:C0051696 | lld:lifeskim |
| pubmed-article:9269636 | lifeskim:mentions | umls-concept:C0599946 | lld:lifeskim |
| pubmed-article:9269636 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:9269636 | pubmed:dateCreated | 1997-10-9 | lld:pubmed |
| pubmed-article:9269636 | pubmed:abstractText | Insulin exerts an antinatriuretic effect when administered acutely in vivo. Interestingly, insulin fails to reduce sodium excretion in rats receiving verapamil. The present study was undertaken in order to investigate whether the calcium-channel blocker amlodipine attenuates the antinatriuretic effect of insulin in humans. | lld:pubmed |
| pubmed-article:9269636 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9269636 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9269636 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9269636 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9269636 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9269636 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9269636 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9269636 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9269636 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9269636 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9269636 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:9269636 | pubmed:issn | 0931-0509 | lld:pubmed |
| pubmed-article:9269636 | pubmed:author | pubmed-author:AlvestrandAA | lld:pubmed |
| pubmed-article:9269636 | pubmed:author | pubmed-author:StenvinkelPP | lld:pubmed |
| pubmed-article:9269636 | pubmed:author | pubmed-author:Ottosson-Seeb... | lld:pubmed |
| pubmed-article:9269636 | pubmed:author | pubmed-author:de PotockiKK | lld:pubmed |
| pubmed-article:9269636 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9269636 | pubmed:volume | 12 | lld:pubmed |
| pubmed-article:9269636 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9269636 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9269636 | pubmed:pagination | 1600-7 | lld:pubmed |
| pubmed-article:9269636 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:9269636 | pubmed:meshHeading | pubmed-meshheading:9269636-... | lld:pubmed |
| pubmed-article:9269636 | pubmed:meshHeading | pubmed-meshheading:9269636-... | lld:pubmed |
| pubmed-article:9269636 | pubmed:meshHeading | pubmed-meshheading:9269636-... | lld:pubmed |
| pubmed-article:9269636 | pubmed:meshHeading | pubmed-meshheading:9269636-... | lld:pubmed |
| pubmed-article:9269636 | pubmed:meshHeading | pubmed-meshheading:9269636-... | lld:pubmed |
| pubmed-article:9269636 | pubmed:meshHeading | pubmed-meshheading:9269636-... | lld:pubmed |
| pubmed-article:9269636 | pubmed:meshHeading | pubmed-meshheading:9269636-... | lld:pubmed |
| pubmed-article:9269636 | pubmed:meshHeading | pubmed-meshheading:9269636-... | lld:pubmed |
| pubmed-article:9269636 | pubmed:meshHeading | pubmed-meshheading:9269636-... | lld:pubmed |
| pubmed-article:9269636 | pubmed:meshHeading | pubmed-meshheading:9269636-... | lld:pubmed |
| pubmed-article:9269636 | pubmed:meshHeading | pubmed-meshheading:9269636-... | lld:pubmed |
| pubmed-article:9269636 | pubmed:meshHeading | pubmed-meshheading:9269636-... | lld:pubmed |
| pubmed-article:9269636 | pubmed:meshHeading | pubmed-meshheading:9269636-... | lld:pubmed |
| pubmed-article:9269636 | pubmed:meshHeading | pubmed-meshheading:9269636-... | lld:pubmed |
| pubmed-article:9269636 | pubmed:meshHeading | pubmed-meshheading:9269636-... | lld:pubmed |
| pubmed-article:9269636 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9269636 | pubmed:articleTitle | A calcium-channel blocker, amlodipine, attenuates insulin antinatriuresis but does not modulate insulin-mediated attenuation of cardiovascular reactivity in healthy man. | lld:pubmed |
| pubmed-article:9269636 | pubmed:affiliation | Department of Clinical Science, Huddinge University Hospital, Karolinska Institute, Stockholm, Sweden. | lld:pubmed |
| pubmed-article:9269636 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9269636 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
